Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

197 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Cash-Producing Stocks We Approach with Caution

By: StockStory

December 11, 2025 at 23:35 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

RMAX Cover Image

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Luckily for you, we built StockStory to help you separate the good from the bad. That said, here are three cash-producing companies to steer clear of and a few better alternatives.

RE/MAX (RMAX)

Trailing 12-Month Free Cash Flow Margin: 11.7%

Short for Real Estate Maximums, RE/MAX (NYSE: RMAX) operates a real estate franchise network spanning over 100 countries and territories.

Why Should You Sell RMAX?

Sluggish trends in its agents suggest customers aren’t adopting its solutions as quickly as the company hoped
Incremental sales over the last five years were much less profitable as its earnings per share fell by 7.1% annually while its revenue grew
Capital intensity will likely increase as its free cash flow margin is anticipated to drop by 8 percentage points over the next year

RE/MAX’s stock price of $8.37 implies a valuation ratio of 6.6x forward P/E. To fully understand why you should be careful with RMAX, check out our full research report (it’s free for active Edge members).

Service International (SCI)

Trailing 12-Month Free Cash Flow Margin: 14.4%

Founded in 1962, Service International (NYSE: SCI) is a leading provider of death care products and services in North America.

Why Do We Avoid SCI?

Number of funeral services performed has disappointed over the past two years, indicating weak demand for its offerings
Poor free cash flow margin of 14.3% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

Service International is trading at $79.28 per share, or 18.7x forward P/E. Dive into our free research report to see why there are better opportunities than SCI.

Hologic (HOLX)

Trailing 12-Month Free Cash Flow Margin: 18.9%

As a pioneer in 3D mammography technology that has revolutionized breast cancer detection, Hologic (NASDAQ: HOLX) develops and manufactures diagnostic products, medical imaging systems, and surgical devices focused primarily on women's health and wellness.

Why Are We Wary of HOLX?

Constant currency revenue growth has disappointed over the past two years and shows demand was soft
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 20.6 percentage points
Diminishing returns on capital suggest its earlier profit pools are drying up

At $74.96 per share, Hologic trades at 16.4x forward P/E. Check out our free in-depth research report to learn more about why HOLX doesn’t pass our bar.

Stocks We Like More

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	270.13	+0.00 (0.00%)
AAPL	298.87	+0.00 (0.00%)
AMD	445.50	+0.00 (0.00%)
BAC	49.84	+0.00 (0.00%)
GOOG	399.04	+0.00 (0.00%)
META	616.63	+0.00 (0.00%)
MSFT	405.21	+0.00 (0.00%)
NVDA	225.83	+0.00 (0.00%)
ORCL	189.76	+0.00 (0.00%)
TSLA	445.27	+0.00 (0.00%)